Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Michael Mancino

Concepts (132)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Opioid-Related Disorders
14
2025
393
3.140
Why?
Buprenorphine
8
2023
146
2.590
Why?
Amphetamine-Related Disorders
5
2024
93
2.150
Why?
Methamphetamine
5
2024
195
1.990
Why?
Cocaine-Related Disorders
7
2025
209
1.830
Why?
Methadone
7
2025
183
1.720
Why?
Opiate Substitution Treatment
9
2025
99
1.560
Why?
Central Nervous System Stimulants
2
2024
209
1.390
Why?
Substance Withdrawal Syndrome
5
2021
167
1.170
Why?
Disulfiram
3
2025
13
1.150
Why?
Alcohol Deterrents
2
2025
11
1.060
Why?
Tai Ji
1
2023
22
0.830
Why?
Patient Discharge
1
2024
319
0.760
Why?
Dextroamphetamine
1
2021
39
0.750
Why?
Analgesics, Opioid
6
2023
576
0.710
Why?
Sertraline
3
2017
46
0.670
Why?
Patient Compliance
3
2016
233
0.650
Why?
Narcotics
3
2025
113
0.630
Why?
Cyclohexanecarboxylic Acids
2
2014
20
0.550
Why?
Double-Blind Method
6
2025
710
0.540
Why?
Amines
2
2014
42
0.540
Why?
gamma-Aminobutyric Acid
2
2014
65
0.530
Why?
Adult
21
2025
13636
0.530
Why?
Child Abuse
1
2016
136
0.460
Why?
Depression
3
2014
580
0.450
Why?
Stress Disorders, Post-Traumatic
2
2010
383
0.420
Why?
Methadyl Acetate
2
2010
11
0.410
Why?
Young Adult
7
2024
4114
0.410
Why?
Male
21
2025
25991
0.400
Why?
Female
22
2025
27181
0.400
Why?
Humans
27
2025
50673
0.370
Why?
Reward
1
2010
115
0.330
Why?
Middle Aged
13
2025
12648
0.330
Why?
Dose-Response Relationship, Drug
6
2025
1376
0.320
Why?
Behavior Therapy
1
2010
185
0.290
Why?
Diagnosis, Dual (Psychiatry)
3
2014
41
0.280
Why?
Treatment Outcome
6
2025
5294
0.270
Why?
Pilot Projects
4
2021
701
0.270
Why?
Cocaine
3
2025
183
0.270
Why?
Quality-Adjusted Life Years
1
2006
64
0.260
Why?
Narcotic Antagonists
4
2021
136
0.240
Why?
Anxiety
2
2022
286
0.240
Why?
Retrospective Studies
6
2022
6294
0.240
Why?
Health Status
1
2006
300
0.230
Why?
Veterans
2
2010
574
0.230
Why?
Combined Modality Therapy
4
2017
642
0.220
Why?
Substance-Related Disorders
2
2024
613
0.220
Why?
Patient Admission
1
2024
76
0.220
Why?
Databases, Factual
2
2019
676
0.190
Why?
Adolescent
4
2024
6489
0.180
Why?
Time Factors
4
2011
2948
0.180
Why?
Outpatients
1
2022
121
0.180
Why?
Quality of Life
1
2006
858
0.170
Why?
Naloxone
2
2013
82
0.170
Why?
Pain
1
2023
386
0.170
Why?
Chromatography, High Pressure Liquid
1
2021
326
0.170
Why?
Tandem Mass Spectrometry
1
2021
239
0.170
Why?
Health Services Accessibility
1
2024
426
0.160
Why?
Self Report
3
2016
206
0.160
Why?
Patient Dropouts
2
2016
51
0.160
Why?
Prescription Drug Misuse
1
2019
34
0.150
Why?
Drug Monitoring
1
2019
82
0.150
Why?
Substance Abuse Treatment Centers
2
2024
79
0.140
Why?
Cross-Sectional Studies
2
2016
1613
0.140
Why?
Age Factors
2
2010
1120
0.140
Why?
Ambulatory Care
2
2016
243
0.140
Why?
Life Change Events
1
2016
36
0.130
Why?
Prevalence
2
2016
975
0.130
Why?
Prospective Studies
3
2021
2395
0.110
Why?
GABA Agonists
1
2014
14
0.110
Why?
Logistic Models
1
2016
902
0.110
Why?
Risk-Taking
1
2014
107
0.110
Why?
Diltiazem
1
2013
10
0.100
Why?
Excitatory Amino Acid Antagonists
1
2013
51
0.100
Why?
Verapamil
1
2013
22
0.100
Why?
Suicidal Ideation
1
2014
96
0.100
Why?
Drug Therapy, Combination
1
2014
388
0.100
Why?
Suicide
1
2014
83
0.100
Why?
Calcium Channel Blockers
1
2013
63
0.100
Why?
Medication Adherence
1
2014
142
0.100
Why?
Recurrence
1
2014
663
0.100
Why?
Motivation
1
2014
278
0.100
Why?
Internet
1
2014
262
0.100
Why?
Electrocardiography
1
2013
267
0.090
Why?
Severity of Illness Index
3
2013
982
0.090
Why?
Token Economy
1
2010
33
0.090
Why?
Substance Abuse Detection
1
2010
92
0.090
Why?
Affect
1
2011
103
0.090
Why?
Income
1
2010
101
0.080
Why?
Hospitals, Veterans
1
2010
111
0.080
Why?
Psychiatric Status Rating Scales
2
2011
319
0.080
Why?
Choice Behavior
1
2010
83
0.080
Why?
Sleep
1
2011
183
0.080
Why?
Heart Rate
1
2011
306
0.080
Why?
Benzhydryl Compounds
1
2009
64
0.080
Why?
Survival Analysis
1
2010
661
0.070
Why?
Blood Pressure
1
2011
531
0.070
Why?
Arkansas
1
2014
1973
0.070
Why?
Cognition
1
2011
346
0.070
Why?
Socioeconomic Factors
1
2010
594
0.070
Why?
Personality Inventory
1
2006
47
0.070
Why?
Child
2
2016
6976
0.070
Why?
United States
2
2024
5012
0.070
Why?
Combat Disorders
1
2006
37
0.070
Why?
Psychometrics
1
2006
231
0.060
Why?
Comorbidity
1
2006
626
0.060
Why?
Depressive Disorder
1
2006
336
0.060
Why?
Single-Blind Method
1
2023
114
0.050
Why?
Secondary Prevention
2
2013
80
0.050
Why?
Limit of Detection
1
2021
17
0.050
Why?
Linear Models
1
2021
283
0.040
Why?
Postpartum Period
1
2021
101
0.040
Why?
Randomized Controlled Trials as Topic
1
2023
569
0.040
Why?
Effect Modifier, Epidemiologic
1
2017
7
0.040
Why?
Reproducibility of Results
1
2021
1199
0.040
Why?
Predictive Value of Tests
1
2019
929
0.030
Why?
Chronic Pain
1
2019
183
0.030
Why?
Emergency Service, Hospital
1
2019
489
0.030
Why?
Risk Assessment
1
2019
1271
0.030
Why?
Pregnancy
1
2021
2456
0.030
Why?
Directly Observed Therapy
1
2013
7
0.030
Why?
Maintenance Chemotherapy
1
2013
48
0.030
Why?
Residence Characteristics
1
2014
151
0.030
Why?
Diagnostic and Statistical Manual of Mental Disorders
1
2013
74
0.030
Why?
Induction Chemotherapy
1
2013
59
0.030
Why?
Calcium Channels, L-Type
1
2013
68
0.030
Why?
Drug Interactions
1
2013
207
0.020
Why?
Placebos
1
2011
87
0.020
Why?
Kaplan-Meier Estimate
1
2011
463
0.020
Why?
Alcohol Drinking
1
2010
229
0.020
Why?
Sex Characteristics
1
2008
199
0.020
Why?
Aged
1
2014
9770
0.010
Why?
Mancino's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description